Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — FY2026 Earnings Presentation
31 slides from Amrutanjan Health Care's earnings presentation, May 8, 2026
Slide 1: Cover letter to stock exchanges
AHCL/SE/9/2026-27 May 9, 2026 The National Stock Exchange oflndia BSE Limited Limited Department of Corporate Services "Exchange Plaza", C-1, Block G I st Floor, Bandra-Kurla Complex, Bandra (E) P.J. Towers, Dalal Street, Mumbai 400 051 Mumbai 400 00 I ISIN: INE098F0 I 031 Symbol: AMRUTANJAN Scrip C
Slide 2: Amrutanjan Health Care Limited Investor Presentation
Amrutanjan Health Care Limited Investor Presentation Quarter & Year Ended 31st March 2026 Date: 8th May 2026
Slide 3: Contents
Contents a. Business Update 1. Segment Performance 2. Activities 3. Operations b. Financials 1. Q4 FY26 Performance 2. FY26 Performance c. Management Commentary Investor Presentation | Quarter and Year Ended 31st March 2026
Slide 4: Business Update
Business Update Investor Presentation | Quarter and Year Ended 31st March 2026
Slide 5: AHCL Power Brands
AHCL Power Brands (Gross Sales Nos.) Brand Amrutanjan Brand Relief Pain Management: Congestion: 342.1 Crs 19.0 Crs Brand Comfy Brand Enerlyte/ Electro+ Women’s Hygiene: Rehydration: 151.6 Crs 35.6 Crs Investor Presentation | Quarter and Year Ended 31st March 2026
Slide 6: FY 25-26: Pain Management and Women's Hygiene witnessed double digit growth
FY 25-26: Pain Management and Women’s Hygiene witnessed double digit growth (Gross Sales Growth) Pain Management Congestion Women’s Hygiene Rehydration Brand Amrutanjan Brand Relief Brand Comfy Brand Electro+ Growth FY 25-26 Growth FY 25-26 Growth FY 25-26 Growth FY 25-26 Overall Pain Category 10% R
Slide 7: Segment Performance: Pain Management
Segment Performance: Pain Management Head ache (Brand Amrutanjan) Body ache (Brand Amrutanjan) Gross Sales Growth Drivers (FY 25-26): All variants (Yellow Balm, White Gross Sales Growth Drivers (FY 25-26): Growth led by Back Pain Roll On Balm and Head Roll On) contributed to the growth (BPRO) and Ma
Slide 8: Segment Performance: Congestion and Women's Hygiene
Segment Performance: Congestion and Women’s Hygiene Congestion (Brand Relief) Women’s Hygiene (Brand Comfy) Gross Sales Growth Drivers (FY 25-26): Gross Sales Growth Drivers (FY 25-26): Relief Inhaler 16% Comfy XL Variant 44% Relief Rubs 15% Value Pack (18 Units Pack) 42% Increase in XL Variant’s co
Slide 9: AHCL's Growth Framework
AHCL’s Growth Framework Key Strategic Objectives • Increasing Penetration by strengthening our presence in core markets – driving LUPs, Rural distribution • Continuous investment and developing low contribution markets • Expanding Comfy into a ‘Overall Women’s Wellness’ brand • Innovation: Expanding
Slide 10: New Launches
New Launches Personal Care: Razors and Antiseptic Plaster • In line with our strategic objectives, AHCL entered into new categories, that complements the existing portfolio • Across categories, the following brands were launched during Q4: • Women’s Razors • Men’s Razors • Antiseptic Plaster • Ortho
Slide 11: New Launches: Personal Care
New Launches: Personal Care Personal Care: Razors and Antiseptic Plaster Smoothe Men’s Razors Comfy Women’s Razors Range Amrutanjan Plastry Investor Presentation | Quarter and Year Ended 31st March 2026
Slide 12: New Launches: Ortho Pain and Congestion
New Launches: Ortho Pain and Congestion Ortho Pain and Nasal Care Advanced Ortho Pain Relief Oil Relief Nasal Spray Investor Presentation | Quarter and Year Ended 31st March 2026
Slide 13: Van Initiative: Reaching the Retailers in Small Towns and Villages
Van Initiative: Reaching the Retailers in Small Towns and Villages Rural Van Activity • Objective: Expand rural market coverage for AHCL by strengthening distributor and sub-distributor network – Drive awareness and promotion of our product portfolio in rural markets. The van activity continued in Q
Slide 14: Marketing Interventions: Head ache and Body ache
Marketing Interventions: Head ache and Body ache In-Store Activities: Pain Category Shop Board: Pain Category Objective: Showcase the complete product range to drive consumer • Objective of the activity: Build awareness and Consideration for Pain Category awareness • Markets: Tamil Nadu Strengthen i
Slide 15: Marketing Interventions: Head ache and Body ache
Marketing Interventions: Head ache and Body ache In-Store Activities: Ortho Oil Consumer Engagement: Sampling • Objective of the activity: Build awareness and Consideration Objective: To drive Awareness and Trial. The touch points include high • Markets: Andhra Pradesh, Assam, Delhi, Jharkhand, Karn
Slide 16: Marketing Interventions: Women's Hygiene
Marketing Interventions: Women’s Hygiene TV Campaign Consumer Engagement: Sampling AHCL continued with the high impact TV campaign in Q4 FY 25-26 as well Objective: To drive Awareness and Trial Objective: To drive awareness for Comfy and its variants Markets: The activity was done in schools in the
Slide 17: Marketing Interventions: Women's Hygiene
Marketing Interventions: Women’s Hygiene Visibility: Cash & Carry Shop Board: Comfy Objective: Creating visibility in B-2-B Chains to help in volume purchase Objective: To drive Awareness and Consideration Markets: Karnataka, Telangana, West Bengal Markets: Uttar Pradesh and Bihar Visibility Shop Bo
Slide 18: Operations Update – Sales and Distribution
Operations Update – Sales and Distribution Distribution Sales In line with AHCL’s strategic priorities, several focused execution enhancement initiatives were implemented to improve operational effectiveness. These Interventions resulted in positive momentum across key sales metrics during the year.
Slide 19: Operations Update – HR
Operations Update – HR HR Initiatives Labour Codes Transition Digitisation Projects • Worked on the financial impact • HR had initiated HR analytics for the Company module through our HRMS, • Initiated restructuring of the VIBE (Social media platform and salary in line with the code on digitized R &
Slide 20: Financials
Financials Investor Presentation | Quarter and Year Ended 31st March 2026
Slide 21: Explanatory Notes
Explanatory Notes IND AS 115 Adjustments on Revenue: ➢ An entity shall account for consideration payable to a customer as a reduction of the transaction price and, therefore, of revenue. Consideration payable to a customer includes cash amounts that an entity pays, or expects to pay, and also includ
Slide 22: Financials – Q4 FY26
Financials – Q4 FY26 (Rs. in Crores) Net Sales Profit before exceptional items 28.62 149.77 135.41 20.86 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Growth: 10.60% Growth: 37.20% Profit Before Tax Profit After Tax 21.02 20.86 16.19 15.18 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Growth: 0.77% Growth: 6.65% Investor Prese
Slide 23: Segment results – Q4 FY26
Segment results – Q4 FY26 (Rs. in Crores) Net Sales – Women’s Hygiene & Personal Care 41.84 34.46 Net Sales – OTC Products 132.63 117.24 Q4 FY26 Q4 FY25 Growth: 21.42% Q4 FY26 Q4 FY25 Net Sales – Comfy (Included in above) 40.79 Growth: 13.13% 34.46 Q4 FY26 Q4 FY25 # Growth: 18.37% # Comfy growth in
Slide 24: Segment results – Q4 FY26
Segment results – Q4 FY26 (Rs. in Crores) Net Sales - Beverages 16.42 17.67 Q4 FY26 Q4 FY25 Net Sales – Hydration drinks (Included in above) 15.47 16.21 Q4 FY26 Q4 FY25 Investor Presentation | Quarter and Year Ended 31st March 2026
Slide 25: Financials – FY26
Financials – FY26 (Rs. in Crores) Net Sales Profit before exceptional items 502.55 86.74 451.82 69.13 FY26 FY25 FY26 FY25 Growth: 11.23% Growth: 25.47% Profit Before Tax Profit After Tax 77.89 57.92 69.13 50.83 FY26 FY25 FY26 FY25 Growth: 12.67% Growth: 13.95% Investor Presentation | Quarter and Yea
Slide 26: Segment results – FY26
Segment results –FY26 (Rs. in Crores) Net Sales – Women’s Hygiene & Personal Care 139.91 123.96 Net Sales – OTC Products 468.22 413.99 FY26 FY25 Growth: 12.87% FY26 FY25 Net Sales – Comfy (Included in above) 138.86 Growth: 13.10% 123.96 FY26 FY25 Growth: 12.02% # Notes: • Majority of Raw material &
Slide 27: Segment results – FY26
Segment results –FY26 (Rs. in Crores) Net Sales - Beverages 36.43 31.56 • Raw material prices are higher than FY25 and Packing material prices are FY26 FY25 marginally lower than FY25. Net Sales - Electro Plus (Included in above) • Advertisement spend for FY26 is at 29.23 32.47 Rs. 3.47 Cr against R
Slide 28: Expenses – FY26
Expenses – FY26 (Rs. in Crores) Employee Benefit Expenses 63.76 59.10 FY26 FY25 Increase : 7.88% Advertisement & Selling Expenses Other Expenses 60.04 58.71 55.20 56.11 FY26 FY25 FY26 FY25 Increase : 7.00% Increase : 6.36% Investor Presentation | Quarter and Year Ended 31st March 2026
Slide 29: Management Commentary
Management Commentary Investor Presentation | Quarter and Year Ended 31st March 2026
Slide 30: Management Commentary
Management Commentary • Your management team closed the year with an exceptional delivery on operating profits( up by 34%, before exceptional items ) top line growth of (11%) • Our relentless focus on growing the power brands of Amrutanjan and Comfy enabled this growth. • We witnessed growth across
Slide 31: Investor Presentation | Quarter and Year Ended 31st March 2026
Investor Presentation | Quarter and Year Ended 31st March 2026
Amrutanjan Health Care — FY2026 Earnings Presentation on 6ix